Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:12 PM
Ignite Modification Date:
2025-12-24 @ 10:12 PM
NCT ID:
NCT03834935
Eligibility Criteria:
Inclusion Criteria:
* Pityriasis alba Patients confirmed by a board certified dermatologist
* Age over 2 years
* Written informed consent signed by the patients or the legal guardians of patients younger than 18 years in the native language (Arabic)
Exclusion Criteria:
* Other concomitant dermatosis (except atopic dermatitis)
* Use of topical steroids, or topical agents other than emollients and sunscreen, in the last 4 weeks
* Known allergy to pimecrolimus
* Pregnant and nursing women
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
2 Years
Study:
NCT03834935
Study Brief:
Protocol Section:
NCT03834935